Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 313,45
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: moluna, Greven, Deutschland
EUR 339,25
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predispo.
Sprache: Englisch
Verlag: Kluwer Boston Incorporated, 1996
ISBN 10: 0792335988 ISBN 13: 9780792335986
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. This title presents a comprehensive review of some of the most crucial and challenging aspects of the infectious complications in cancer patients. Editor(s): Klastersky, Jean. Series: Cancer Treatment and Research. Num Pages: 290 pages, black & white illustrations. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 17. Weight in Grams: 1330. . 1996. 1995th Edition. hardcover. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Springer Nature B.V. Jan 1996, 1996
ISBN 10: 0792335988 ISBN 13: 9780792335986
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predisposing condition to a variety of infections. These adverse events are still with us, in spite of much progress in the therapy of infectious disease, since cancer therapy is becoming more aggressive, yet further lowering the host's capacity to cope with infections. Moreover, the pathogens adapt effectively to drugs, and at a pace that might outrun industry's capability to produce new agents. Finally, new pathogens are appearing as a consequence of both selection and severe immunosuppression. Infection is so common among cancer patients that its diagnosis and management represent a daily challenge to all oncologists, who must continually strive to keep abreast of developments in the area. The present comprehensive review of the most crucial and challenging aspects of the infectious complications in cancer patients will help them to do just that.